Genprex, Inc. (GNPX) News
Follow Genprex, Inc. (GNPX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Genprex to present at H.C. Wainwright 28th Global Investment Conference
Genprex (GNPX) will present at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 08, 2026, 12:01 PM UTC
L
GNPX selects contract manufacturer for diabetes gene therapy scale-up
Genprex (GNPX) selected a leading clinical and commercial contract development and manufacturing organization to support manufacturing scale-up for its diabetes gene therapy; no deal size or timing was provided.
EQUITY | Aug 18, 2026, 11:00 AM UTC
H
Genprex Collaborates with Roche Diagnostics
Genprex partners with Roche Diagnostics for biomarker studies
EQUITY | Aug 03, 2026, 11:00 AM UTC
M
GNPX: Receives Patent Notice
Genprex receives notice of allowance from CIPO for patent covering use of Reqorsa gene therapy in combination with either PD-1 or PD-L1 antibodies for treatment of lung cancer
EQUITY | Jun 22, 2026, 01:10 PM UTC
H
GNPX Receives Patent Notice
Genprex receives a notice of allowance from the Canadian Intellectual Property Office for a patent claiming the combination of Reqorsa gene therapy with either PD-1 or PD-L1 antibodies to treat cancer
EQUITY | Jun 22, 2026, 01:03 PM UTC